跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TECARTUS 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TECARTUS 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION
Approved
STANDARD
TECARTUS 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION
Kite Pharma Eu B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 27, 2020
Approval ID
e542a81e4e7aa25a
Company
Kite Pharma Eu B.V.
Type
Standard
Approval Details
Approval Id
e542a81e4e7aa25a
Drug Cima Aemps Name
TECARTUS 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION
Register Number
1201492001
Holder Company Name
Kite Pharma Eu B.V.
Marketing Company Name
Gilead Sciences S.L.
Holder Company Detail Path
/organization/kite-pharma-eu-bv
Authorization Date
2020-12-27
Dosage Form
DISPERSION PARA PERFUSION
Dose
0,4 - 2 x 10e8 células inyectable 68 ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Kite Pharma Eu B.V.
Company Detail Path
/organization/kite-pharma-eu-bv
Company Information
Pharmaceutical Company Name
Kite Pharma EU B.V.
Name En
Kite Pharma EU B.V.
Country Name
Netherlands
Website
http://www.kitepharma.com
Active Ingredients
BREXUCABTAGEN AUTOLEUCEL
1 × 10e6 a 2 x 10e6 CELULAS
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 27, 2020
Approval ID
e542a81e4e7aa25a
Type
Standard
Back to CIMA-AEMPS Approvals